Abstract
The use of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) has become commonplace in the study of neuronal development, physiology, disease modelling, and therapy development. Due to the transient nature of working with these cells, it is important to regularly confirm the cell status as a naive stem cell versus a more defined neural progenitor cell (NPC). Classically, this has been done using a panel of specific antibodies to test for the expression of transcription factors known to be observed in ESCs, but not NPCs. However, this method is both time consuming and expensive. Here, we describe the use of the NanoString nCounter system for determining the levels of expression of key transcription factors that will effectively aid in determining the state of your stem cell cultures.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rossant J (2008) Stem cells and early lineage development. Cell 132:527–531
Silva J, Smith A (2008) Capturing pluripotency. Cell 132:532–536
Chen X, Xu H, Yuan P et al (2008) Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133:1106–1117
Jaenisch R, Young R (2008) Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132:567–582
Macarthur BD, Ma’ayan A, Lemischka IR (2009) Systems biology of stem cell fate and cellular reprogramming. Nat Rev Mol Cell Biol 10:672–681
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676
Carcamo-Orive L, Hoffman GE, Cundiff P et al (2017) Analysis of transcriptional variability in a large human iPSC library reveals genetic and non-genetic determinants of heterogeneity. Cell Stem Cell 20(4):518–532
Cayo M, Mallanna S, Di Furio F et al (2017) A drug screen using human iPSC-derived hepatocyte-like cells reveals cardiac glycosides as a potential treatment for hypercholesterolemia. Cell Stem Cell 20(4):478–489
Sahakyan A, Kim R, Chronis C et al (2017) Human naïve pluripotent stem cells model X chromosome dampening and X inactivation. Cell Stem Cell 20(1):87–101
Vallot C, Patrat C, Collier AJ et al (2017) XACT noncoding RNA competes with XIST n the control of X chromosome activity during human early development. Cell Stem Cell 20(1):102–111
Weinberger L, Ayyash M, Novershtern N et al (2016) Dynamic stem cell states: naïve to primed pluripotency in rodents and humans. Nat Rev Mol Cell Biol 17(3):155–169
Boyer L, Lee T, Cole M et al (2005) Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122:947–956
Kim J, Chu J, Shen X et al (2008) An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132:1049–1061
Avilion A, Nicolis SK, Pevny LH et al (2003) Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 17:126–140
Chambers I, Colby D, Robertson M et al (2003) Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113:643–655
Hendrickson M, Rao A, Demerdash O et al (2011) Expression of nestin by neural cells in the adult rat and human brain. PLoS One 6(4):e18535
Zhang X, Huang CT, Chen J et al (2010) Pax6 is a human neuroectoderm cell fate determinant. Cell Stem Cell 7(1):90–100
Zhao S, Nichols J, Smith AG et al (2004) SoxB transcription factors specify neuroectodermal lineage choice in ES cells. Mol Cell Neurosci 27:332–342
Geiss G, Bumgarner R, Birditt B et al (2008) Direct multiplexed measurement of gene expression with color-coded probes. Nat Biotechnol 26(3):317–325
Synnergren J, Giesler TL, Adak S et al (2007) Differentiating human embryonic stem cells express a unique housekeeping gene signature. Stem Cells 25(2):473–480
Acknowledgments
Funding support from the Canadian Institute of Health Research (CIHR) Graduate Scholarship (S.R.).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Ryall, S., Arnoldo, A., Sheth, J., Singh, S.K., Hawkins, C. (2019). Detecting Stem Cell Marker Expression Using the NanoString nCounter System. In: Singh, S., Venugopal, C. (eds) Brain Tumor Stem Cells. Methods in Molecular Biology, vol 1869. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8805-1_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8805-1_5
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8804-4
Online ISBN: 978-1-4939-8805-1
eBook Packages: Springer Protocols